Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i> -Mutated Advanced Urothelial CarcinomaSumati Gupta, Sunil Sharma, Alexis Weston et al.|Molecular Cancer Therapeutics|2018Cited by 24
Supplemental figure 4 from Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial CarcinomaSumati Gupta, Sunil Sharma, Daniel J. Albertson et al.|Unknown|2023Cited by 0